Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Vagal Nerve Stimulation for Interoception Modulation

NCT: NCT03603730 · COMPLETED

NCT IDNCT03603730
StatusCOMPLETED
Start Date2023-07-11
Completion2026-03-31
SponsorMassachusetts General Hospital (OTHER)
First posted
Last updated

Brief Summary

Explore the effects of variable ingested volumes and auricular transcutaneous vagal nerve stimulation (taVNS) on brain and stomach outcomes in healthy adults.

Frequently Asked Questions

What is Vagal Nerve Stimulation for Interoception Modulation?

Vagal Nerve Stimulation for Interoception Modulation is a clinical trial registered under NCT03603730. Current status: COMPLETED.

What is the status of NCT03603730?

The current status of NCT03603730 (Vagal Nerve Stimulation for Interoception Modulation) is: COMPLETED.

When did Vagal Nerve Stimulation for Interoception Modulation start?

Vagal Nerve Stimulation for Interoception Modulation started on 2023-07-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑